The price of Clover Health Investments Corp (NASDAQ:CLOV) shares last traded on Wall Street fell -3.46% to $0.92.
Based on available information, 3 analysts follow Clover Health Investments Corp (NASDAQ:CLOV). The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $2.00 and a low of $1.00, we find $1.00. Given the previous closing price of $0.95, this indicates a potential upside of 5.26 percent. CLOV stock price is now -6.17% away from the 50-day moving average and -9.18% away from the 200-day moving average. The market capitalization of the company currently stands at $449.51M.
Among analysts, 2 rate the stock a hold while 1 rate it a buy. Brokers who have rated the stock have averaged $1.33 as their price target over the next twelve months.
With the price target reduced from $7 to $3, Cowen Upgraded its rating from Underperform to Market Perform for Clover Health Investments Corp (NASDAQ: CLOV).
In other news, Loengard Anna U, Director bought 11,000 shares of the company’s stock on Sep 06. The stock was bought for $14,300 at an average price of $1.30. Upon completion of the transaction, the Director now directly owns 10,000 shares in the company, valued at $9200.0. Insiders disposed of 1,931,421 shares of company stock worth roughly $1.78 million over the past 1 year. A total of 24.02% of the company’s stock is owned by insiders.
A candlestick chart of Clover Health Investments Corp (NASDAQ: CLOV) showed a price of $0.9555 on Tuesday morning. During the past 12 months, Clover Health Investments Corp has had a low of $0.71 and a high of $1.63. The fifty day moving average price for CLOV is $0.9824 and a two-hundred day moving average price translates $1.0150 for the stock.
The latest earnings results from Clover Health Investments Corp (NASDAQ: CLOV) was released for Sep, 2023. According to the Healthcare Plans Company, earnings per share came in at -$0.09, beating analysts’ expectations of -$0.11 by 0.02. This compares to -$0.16 EPS in the same period last year. The net profit margin was -9.37% and return on equity was -63.58% for CLOV. The company reported revenue of $482.07 million for the quarter, compared to $856.82 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -43.74 percent. For the current quarter, analysts expect CLOV to generate $485.5M in revenue.
